RNAM
NASDAQAvidity Biosciences Inc.
IPO2020
Avidity Biosciences Inc. (RNAM) is a public company listed on NASDAQ. There were no new wire items for RNAM in the last 30 days. The most recent was published Mar 9, 2026.
Latest news
25 items- SECSEC Form 15-12G filed by Avidity Biosciences Inc.15-12G - Avidity Biosciences, Inc. (0001599901) (Filer)
- INSIDERChief Human Resources Officer Mccarthy Teresa returned 165,296 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- INSIDERDirector Thompson Tamar returned 6,692 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- INSIDERChief Financial Officer Maclean Michael F returned 133,977 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- INSIDERDirector Skerjanec Simona returned 6,692 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- INSIDERChief Medical Officer Hughes Steven George returned 115,857 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- INSIDERPresident and CEO Boyce Sarah returned 474,861 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- INSIDERChief Legal Officer Moriarty John B returned 92,054 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- INSIDERChief Scientific Officer Flanagan W. Michael returned 150,365 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- INSIDERDirector Wilson Troy Edward returned 78,802 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- INSIDERChief Program Officer Gallagher Kathleen P. returned 80,303 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- INSIDERDirector Henig Noreen returned 6,692 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- INSIDERDirector Kim Jean Jinsun returned 6,692 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- INSIDERDirector Levin Arthur A returned 147,934 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- INSIDERDirector Kaye Edward M. Md returned 6,692 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- INSIDERDirector Boess Carsten returned 6,692 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- INSIDERChief Commercial Officer Mosbrooker Eric returned 79,413 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- INSIDERChief Technical Officer Calderaro Charles Iii returned 98,547 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- SECSEC Form 25-NSE filed by Avidity Biosciences Inc.25-NSE - Avidity Biosciences, Inc. (0001599901) (Subject)
- SECSEC Form POSASR filed by Avidity Biosciences Inc.POSASR - Avidity Biosciences, Inc. (0001599901) (Filer)
- SECSEC Form POSASR filed by Avidity Biosciences Inc.POSASR - Avidity Biosciences, Inc. (0001599901) (Filer)
- SECSEC Form POSASR filed by Avidity Biosciences Inc.POSASR - Avidity Biosciences, Inc. (0001599901) (Filer)
- SECSEC Form S-8 POS filed by Avidity Biosciences Inc.S-8 POS - Avidity Biosciences, Inc. (0001599901) (Filer)
- SECSEC Form S-8 POS filed by Avidity Biosciences Inc.S-8 POS - Avidity Biosciences, Inc. (0001599901) (Filer)
- SECSEC Form S-8 POS filed by Avidity Biosciences Inc.S-8 POS - Avidity Biosciences, Inc. (0001599901) (Filer)
RNAM FAQ
4 questionsWhat is the latest news on RNAM?
Quantisnow has not tracked any new filings, ratings or press releases for RNAM in the last 30 days. The most recent wire item was published on March 9, 2026.Where does RNAM stock trade?
Avidity Biosciences Inc. (RNAM) is listed on NASDAQ.When did Avidity Biosciences Inc. go public?
Avidity Biosciences Inc. (RNAM) completed its IPO in 2020.How can I track RNAM on Quantisnow?
Quantisnow aggregates Avidity Biosciences Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow RNAM to receive live email and push alerts on every new disclosure.